GlassScriptPhysician profile
Andrew K Cheng
NPI 1376040162
$2,171.96
in general payments reported to CMS, 2019-2025
14 companies · $46.33 in 2025
The $46.33 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $46.56 · 2021: $144 · 2022: $580 · 2023: $924 · 2024: $431 · 2025: $46.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,180 · Travel and Lodging: $221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,180.23 |
| Travel and Lodging | $220.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $481.63 | 2022-2024 | Dalvance |
| Elevate Surgical Co | $431.00 | 2022 | |
| Arthrex, INC. | $410.28 | 2023 | |
| Paragon 28, INC. | $249.61 | 2021-2023 | Tenotac 2.0 |
| Integra Lifesciences Corporation | $120.11 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Smith+Nephew, INC. | $108.20 | 2020-2022 | |
| Gilead Sciences, INC. | $104.29 | 2023 | |
| Solventum Corporation | $65.55 | 2024 | Prevena, V.A.C. Dermatac, V.A.C. Veraflo |
| Bone Support INC. | $62.25 | 2024 | Cerament G, Ceramentbone Void Filler |
| Orthofix Medical, INC. | $45.67 | 2021-2023 | Physio-Stim |
| Bioventus LLC | $28.08 | 2021 | |
| Resmed Corp | $26.38 | 2022 | |
| Evolution Surgical, INC | $21.78 | 2022 | |
| Treace Medical Concepts, INC. | $17.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Cheng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.